Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions

Human Pathology

Volumn 40, Issue 11, 2009, Pages 1534-1542

  Zou, Xiao Ping ^a   Zhang, Bin ^a   Zhang, Xiao Qi ^a   Chen, Min ^b   Cao, Jun ^a   Liu, Wen Jia ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Early gastric adenocarcinoma; Hypermethylation; Immunohistochemistry; Methylation specific PCR; Precancerous lesion

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DEATH ASSOCIATED PROTEIN KINASE; FORMALDEHYDE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PARAFFIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; TRANSCRIPTION FACTOR RUNX3;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER LOCALIZATION; CONTROLLED STUDY; EARLY CANCER; FEMALE; GASTRIC EPITHELIAL DYSPLASIA; GENE EXPRESSION; GENE SILENCING; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSTESTINAL METAPLASIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRECANCER; PROMOTER HYPERMETHYLATION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; STOMACH ADENOCARCINOMA; STOMACH MUCOSA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GENES, P16; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 70349887752     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.01.029     Document Type: Article

References (28)

1. Correa P. A human model of gastric carcinogenesis. Cancer Res 48 13 (1988) 3554-3560
2. Pisani D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80 6 (1999) 827-841
3. Jemal A., Clegg L.X., Ward E., et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101 1 (2004) 3-27
4. Baylin S.B., Herman J.G., Graff J.R., Vertino P.M., and Issa J.P. Alterations in DNA methylation: fundamental aspect of neoplasia. Adv Cancer Res 72 (1998) 141-196
5. Jones P.A., and Laird P.W. Cancer epigenetics comes of age. Nat Genet 21 2 (1999) 163-167
6. Mitsuno M., Kitajima Y., Ide T., et al. Aberrant methylation of p16 predicts candidates for 5-fluorouracilbased adjuvant therapy in gastric cancer patients. J Gastroenterol 42 11 (2007) 866-873
7. Homma N., Tamura G., Honda T., et al. Spreading of methylation within RUNX3 CpG island in gastric cancer. Cancer Sci 97 1 (2006) 51-56
8. 6-methylguanine-DNA methyltransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma. Cancer 92 11 (2001) 2760-2768
9. Kato K., Iida S., Uetake H., et al. Methylated TMS1 and DAPK genes predict prognosis and response to chemotherapy in gastric cancer. Int J Cancer 122 3 (2008) 603-608
10. Byun D.S., Lee M.G., Chae K.S., Ryu B.G., and Chi S.G. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Cancer Res 61 19 (2001) 7034-7038
11. Herman J.G., Graff R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay formethylation status of CpG islands. Proc Natl Acad Sci USA 93 18 (1996) 9821-9826
12. Lo K.W., Kwong J., Hui A.B.Y., et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 61 10 (2001) 3877-3881
13. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59 4 (1999) 793-797
14. 6-methylguanine methyltransferase promoter hypermethylation. J Biol Chem 276 22 (2001) 19052-19058
15. 6-methylguanine DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma. Carcinogenesis 24 6 (2003) 1039-1044
16. INK4a expression in gastric adenocarcinoma. Int J Cancer 87 2 (2000) 236-240
17. Katzenellenbogen R.A., Baylin S.B., and Herman J.G. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood 93 12 (1999) 4347-4353
18. Kang G.H., Lee S., Kim W.H., et al. Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 160 3 (2002) 787-794
19. To K.F., Leung W.K., Lee T.L., et al. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer 102 6 (2002) 623-628
20. Choi N., Son D.S., Song I., et al. RASSF1A is not appropriate as an early detection marker or a prognostic marker for non-small cell lung cancer. Int J Cancer 115 4 (2005) 575-581
21. Belinsky S.A., Palmisano W.A., Gilliland F.D., et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 62 8 (2002) 2370-2377
22. Chan A.O., Lam S.K., Wong B.C., et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 52 4 (2003) 502-506
23. Forman D., Webb P., and Parsonnet J. H. pylori and gastric cancer. Lancet 343 (1994) 243-244
24. Koike H., Ichikawa D., Ikoma H., et al. Comparison of serum aberrant methylation and conventional tumor markers in gastric cancer patients. Hepato-Gastroenterology 52 64 (2005) 1293-1296
25. Jones P.A. The DNA methylation paradox. Trends Genet 15 1 (1999) 34-37
26. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 60 9 (2000) 2368-2371
27. 6-methylguanine-DNA methyltransferase promoter region as a marker of gene silencing. Mol Carcinog 24 2 (1999) 85-89
28. Tokugawa T., Sugihara H., Tani T., and Hattori T. Modes of silencing of p16 in development of esophageal squamous cell carcinoma. Cancer Res 62 17 (2002) 4938-4944